Toll-like receptor 3 ligand-induced antiviral response in mouse osteoblastic cells

International Journal of Molecular Medicine

Volumn 19, Issue 5, 2007, Pages 771-775

  Nakamura, Kimiya ^a   Deyama, Yoshiaki ^a   Yoshimura, Yoshitaka ^a   Suzuki, Kuniaki ^a   Morita, Manabu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CXCL10; Interferon ; Osteoblast; Polyinosinic acid:polycytidylic acid; Toll like receptor 3

Indexed keywords

ALPHA CHEMOKINE; ANTIBODY; ANTIVIRUS AGENT; BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LIGAND; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3;

ANIMAL; ARTICLE; AUTOCRINE EFFECT; BIOLOGICAL MODEL; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; OSTEOBLAST; SERODIAGNOSIS;

ANIMALS; ANTIBODIES; ANTIVIRAL AGENTS; AUTOCRINE COMMUNICATION; CELLS, CULTURED; CHEMOKINES, CXC; GENE EXPRESSION REGULATION; INTERFERON-BETA; LIGANDS; MICE; MODELS, BIOLOGICAL; NEUTRALIZATION TESTS; OSTEOBLASTS; POLY I-C; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 3;

EID: 34248592079     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.5.771     Document Type: Article

References (29)

1. Young MF, Kerr JM, Ibaraki K, Heegaard AM and Robey PG: Structure, expression, and regulation of the major non-collagenous matrix proteins of bone. Clin Orthop Relat Res 281: 275-294, 1992.
2. Chen J, Shapiro HS and Sodek J: Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 7: 987-997, 1992.
3. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT and Martin TJ: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357, 1999. (Pubitemid 30649812)
4. Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T and Higashio K: RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253: 395-400, 1998.
5. Yamaguchi M and Uchiyama S: Receptor activator of NF-κB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Int J Mol Med 14: 81-85, 2004.
6. Kaisho T and Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol 117: 979-987, 2006.
7. Schwandner R, Dziarski R, Wesche H, Rothe M and Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 274: 17406-17409, 1999.
8. Alexopoulou L, Holt AC, Medzhitov R and Flavell RA: Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413: 732-738, 2001.
9. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B and Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
10. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM and Aderem A: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103, 2001.
11. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K and Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745, 2000. (Pubitemid 32015992)
12. Fujisawa H, Kondo S, Wang B, Shivji GM and Sauder DN: The expression and modulation of IFN-α and IFN-β in human keratinocytes. J Interferon Cytokine Res 17: 721-725, 1997. (Pubitemid 28027984)
13. Satomi H, Wang B, Fujisawa H and Otsuka F: Interferon-β from melanoma cells suppresses the proliferations of melanoma cells in an autocrine manner. Cytokine 18: 108-115, 2002. (Pubitemid 34754101)
14. Tohyama M, Dai X, Sayama K, Yamasaki K, Shirakata Y, Hanakawa Y, Tokumaru S, Yahata Y, Yang L, Nagai H, Takashima A and Hashimoto K: dsRNA-mediated innate immunity of epidermal keratinocytes. Biochem Biophys Res Commun 335: 505-511, 2005.
15. Einhorn S, Eldor A, Vlodavsky I, Fuks Z and Panet A: Production and characterization of interferon from endothelial cells. J Cell Physiol 122: 200-204, 1985.
16. Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809, 2001.
17. Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD: How cells respond to interferons. Annu Rev Biochem 67: 227-264, 1998.
18. Taniguchi T, Ogasawara K, Takaoka A and Tanaka N: IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19: 623-655, 2001.
19. Ducy P, Schinke T and Karsenty G: The osteoblast: a sophisticated fibroblast under central surveillance. Science 289: 1501-1504, 2000.
20. Teitelbaum SL: Bone resorption by osteoclasts. Science 289: 1504-1508, 2000.
21. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF and Taniguchi T: RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416: 744-749, 2002.
22. Gasper NA, Petty CC, Schrum LW, Marriott I and Bost KL: Bacterium-induced CXCL10 secretion by osteoblasts can be mediated in part through toll-like receptor 4. Infect Immun 70: 4075-4082, 2002. (Pubitemid 34790915)
23. Doyle SE, O'Connell R, Vaidya SA, Chow EK, Yee K and Cheng G: Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. J Immunol 170: 3565-3571, 2003.
24. Levy DE, Marie I and Prakash A: Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr Opin Immunol 15: 52-58, 2003.
25. Takami M, Kim N, Rho J and Choi Y: Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol 169: 1516-1523, 2002.
26. Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T and Yoshikai Y: Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 166: 3574-3579, 2001. (Pubitemid 33117363)
27. Cinatl J Jr, Michaelis M, Morgenstern B and Doerr HW: High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells. Int J Mol Med 15: 323-327, 2005.
28. Rossi D and Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242, 2000.
29. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M and Moser B: Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 184: 963-969, 1996.